Cargando…
Changes in the treatment rate of patients newly diagnosed with stage IV cancer near the end of life from 2012 to 2017 in Korea
OBJECTIVES: This study aimed to evaluate changes in the cancer treatment rate among patients newly diagnosed with stage IV cancer using socio-demographic and clinical subgroups in a nationwide cohort of Korean patients. METHODS: This retrospective, national-level study used the Korea Central Cancer...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Epidemiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266927/ https://www.ncbi.nlm.nih.gov/pubmed/36791793 http://dx.doi.org/10.4178/epih.e2023021 |
_version_ | 1785058836335296512 |
---|---|
author | Kim, Kyuwoong Jho, Hyun Jung Park, So Jung Park, Bohyun Choi, Jin Young |
author_facet | Kim, Kyuwoong Jho, Hyun Jung Park, So Jung Park, Bohyun Choi, Jin Young |
author_sort | Kim, Kyuwoong |
collection | PubMed |
description | OBJECTIVES: This study aimed to evaluate changes in the cancer treatment rate among patients newly diagnosed with stage IV cancer using socio-demographic and clinical subgroups in a nationwide cohort of Korean patients. METHODS: This retrospective, national-level study used the Korea Central Cancer Registry (KCCR), which is linked to the National Health Insurance Service (NHIS) database, from January 1, 2012 to December 31, 2017. The records of patients newly diagnosed with stage IV of the 5 cancers with the highest cancer-related mortality rate were identified to analyze changes in the treatment rate. The main outcome examined in this study was the change in the cancer treatment rate between 2012 and 2017, as measured using the annual percent change (APC). RESULTS: A total of 106,082 patients with newly diagnosed gastric, colorectal, liver, pancreatic, and lung cancers at the end of life (EoL) were identified from the KCCR-NHIS database. Of these patients, 76,533 (72.1%) received cancer treatment. Over the study period (2012-2017), the proportion of patients who received cancer treatment at EoL decreased by 8.3%, with an APC of -2.1% (95% confidence interval, -2.6 to -1.6). This declining trend of cancer treatment among patients with advanced cancer stage at EoL was consistent among socio-demographic and clinical subgroups. CONCLUSIONS: The proportion of untreated patients with stage IV cancer is increasing in the Korea. For patients who are not undergoing standard cancer treatment near EoL, an alternative care plan, such as early palliative care, should be considered. |
format | Online Article Text |
id | pubmed-10266927 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Korean Society of Epidemiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-102669272023-06-15 Changes in the treatment rate of patients newly diagnosed with stage IV cancer near the end of life from 2012 to 2017 in Korea Kim, Kyuwoong Jho, Hyun Jung Park, So Jung Park, Bohyun Choi, Jin Young Epidemiol Health Original Article OBJECTIVES: This study aimed to evaluate changes in the cancer treatment rate among patients newly diagnosed with stage IV cancer using socio-demographic and clinical subgroups in a nationwide cohort of Korean patients. METHODS: This retrospective, national-level study used the Korea Central Cancer Registry (KCCR), which is linked to the National Health Insurance Service (NHIS) database, from January 1, 2012 to December 31, 2017. The records of patients newly diagnosed with stage IV of the 5 cancers with the highest cancer-related mortality rate were identified to analyze changes in the treatment rate. The main outcome examined in this study was the change in the cancer treatment rate between 2012 and 2017, as measured using the annual percent change (APC). RESULTS: A total of 106,082 patients with newly diagnosed gastric, colorectal, liver, pancreatic, and lung cancers at the end of life (EoL) were identified from the KCCR-NHIS database. Of these patients, 76,533 (72.1%) received cancer treatment. Over the study period (2012-2017), the proportion of patients who received cancer treatment at EoL decreased by 8.3%, with an APC of -2.1% (95% confidence interval, -2.6 to -1.6). This declining trend of cancer treatment among patients with advanced cancer stage at EoL was consistent among socio-demographic and clinical subgroups. CONCLUSIONS: The proportion of untreated patients with stage IV cancer is increasing in the Korea. For patients who are not undergoing standard cancer treatment near EoL, an alternative care plan, such as early palliative care, should be considered. Korean Society of Epidemiology 2023-02-14 /pmc/articles/PMC10266927/ /pubmed/36791793 http://dx.doi.org/10.4178/epih.e2023021 Text en © 2023, Korean Society of Epidemiology https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Kim, Kyuwoong Jho, Hyun Jung Park, So Jung Park, Bohyun Choi, Jin Young Changes in the treatment rate of patients newly diagnosed with stage IV cancer near the end of life from 2012 to 2017 in Korea |
title | Changes in the treatment rate of patients newly diagnosed with stage IV cancer near the end of life from 2012 to 2017 in Korea |
title_full | Changes in the treatment rate of patients newly diagnosed with stage IV cancer near the end of life from 2012 to 2017 in Korea |
title_fullStr | Changes in the treatment rate of patients newly diagnosed with stage IV cancer near the end of life from 2012 to 2017 in Korea |
title_full_unstemmed | Changes in the treatment rate of patients newly diagnosed with stage IV cancer near the end of life from 2012 to 2017 in Korea |
title_short | Changes in the treatment rate of patients newly diagnosed with stage IV cancer near the end of life from 2012 to 2017 in Korea |
title_sort | changes in the treatment rate of patients newly diagnosed with stage iv cancer near the end of life from 2012 to 2017 in korea |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266927/ https://www.ncbi.nlm.nih.gov/pubmed/36791793 http://dx.doi.org/10.4178/epih.e2023021 |
work_keys_str_mv | AT kimkyuwoong changesinthetreatmentrateofpatientsnewlydiagnosedwithstageivcancerneartheendoflifefrom2012to2017inkorea AT jhohyunjung changesinthetreatmentrateofpatientsnewlydiagnosedwithstageivcancerneartheendoflifefrom2012to2017inkorea AT parksojung changesinthetreatmentrateofpatientsnewlydiagnosedwithstageivcancerneartheendoflifefrom2012to2017inkorea AT parkbohyun changesinthetreatmentrateofpatientsnewlydiagnosedwithstageivcancerneartheendoflifefrom2012to2017inkorea AT choijinyoung changesinthetreatmentrateofpatientsnewlydiagnosedwithstageivcancerneartheendoflifefrom2012to2017inkorea |